Baker Avenue Asset Management’s Biogen BIIB Stock Holding History

Baker Avenue Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$607K	Buy	2,808 +601	+27%	+$115K	0.01%	437
2026 Q1	$405K	Buy	2,207 +610	+38%	+$112K	0.01%	500
2025 Q4	$281K	Sell	1,597 -1	-0.1%	-$163	0.01%	523
2025 Q3	$224K	Buy	+1,598	New	+$216K	0.01%	559
2024 Q4	–	Sell	-1,241	Closed	-$241K	–	425
2024 Q3	$241K	Buy	+1,241	New	+$260K	0.01%	378
2023 Q4	–	Sell	-183	Closed	-$47K	–	495
2023 Q3	$47K	Buy	183 +125	+216%	+$33.4K	﹤0.01%	528
2023 Q2	$16.5K	Sell	58 -1	-2%	-$298	﹤0.01%	675
2023 Q1	$16.4K	Buy	59 +1	+2%	+$277	﹤0.01%	694
2022 Q4	$16.1K	Buy	+58	New	+$16.4K	﹤0.01%	650

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baker Avenue Asset Management's BIIB Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Biogen (BIIB) stake by 27% in Q2 2026, buying an estimated $115K and bringing the position to 2,808 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #437.

Baker Avenue Asset Management first reported a position in BIIB in Q4 2022 and has held it in 9 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Baker Avenue Asset Management held 2,808 shares of Biogen worth $607K as of Q2 2026.
Baker Avenue Asset Management bought 601 Biogen shares in Q2 2026, an estimated $115K.
Biogen made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #437 holding.
Baker Avenue Asset Management first reported a position in Biogen in Q4 2022 and has held it in 9 quarters since.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.